Man Group PLC Evolus, Inc. Transaction History

Man Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$7.23 - $10.52 $285,650 - $415,634	-39,509 Reduced 42.29%	53,921 $392,000
Q1 2023 May 15, 2023	BUY	$7.81 - $11.05 $729,688 - $1.03 Million	93,430 New	93,430 $790,000
Q4 2018 Feb 14, 2019	SELL	$10.57 - $19.29 $131,712 - $240,372	-12,461 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.31 - $29.82 $215,699 - $371,587	12,461 New	12,461 $232,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.